Published in PLoS One on January 01, 2010
Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med (2016) 3.04
Management of neurosurgical instruments and patients exposed to Creutzfeldt-Jakob disease. Infect Control Hosp Epidemiol (2013) 2.02
Prion transmission: prion excretion and occurrence in the environment. Prion (2010) 1.17
Epidemiological characteristics of human prion diseases. Infect Dis Poverty (2016) 0.89
Empyema in spinal canal in thoracic region, abscesses in paravertebral space, spondylitis: in clinical course of zoonosis Erysipelothrix rhusiopathiae. Eur Spine J (2012) 0.88
Duration of prion disease is longer in Japan than in other countries. J Epidemiol (2011) 0.86
Molecular pathogenesis of sporadic prion diseases in man. Prion (2012) 0.85
Ethics in prion disease. Prog Neurobiol (2013) 0.83
Ascertainment bias causes false signal of anticipation in genetic prion disease. Am J Hum Genet (2014) 0.79
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) Correlation of Histopathology and MRI in Prion Disease. Alzheimer Dis Assoc Disord (2017) 0.75
Racial and ethnic differences in individuals with sporadic Creutzfeldt-jakob disease in the United States of America. PLoS One (2012) 0.75
A case cluster of variant Creutzfeldt-Jakob disease linked to the Kingdom of Saudi Arabia. Brain (2016) 0.75
Neuroepidemiology and the epidemiology of viral infections of the nervous system. Handb Clin Neurol (2014) 0.75
Prion diseases as transmissible zoonotic diseases. Osong Public Health Res Perspect (2013) 0.75
Melanin or melanin-like substance interacts with the N-terminal portion of prion protein and inhibits abnormal prion protein formation in prion-infected cells. J Virol (2017) 0.75
Prions. Proc Natl Acad Sci U S A (1998) 27.80
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98
Age adjustment using the 2000 projected U.S. population. Healthy People 2010 Stat Notes (2001) 5.76
A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol (2008) 2.95
Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns. Emerg Infect Dis (2001) 2.62
Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain (2003) 2.42
Creutzfeldt-Jakob disease in the United States: 1979-1998. JAMA (2000) 2.09
Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med (1991) 2.05
Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science (2001) 1.93
Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology (2005) 1.88
Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry (1988) 1.87
Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate. PLoS One (2008) 1.56
Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull (2003) 1.41
The public health impact of prion diseases. Annu Rev Public Health (2005) 1.33
Epidemiology of Creutzfeldt-Jakob disease in the United States, 1979-1990: analysis of national mortality data. Neuroepidemiology (1995) 1.22
Monitoring the occurrence of emerging forms of Creutzfeldt-Jakob disease in the United States. Neurology (2003) 1.19
Surveillance for Creutzfeldt-Jakob disease--United States. MMWR Morb Mortal Wkly Rep (1996) 1.12
Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases. Emerg Infect Dis (1997) 1.07
Prion protein misfolding and disease. Curr Opin Struct Biol (2009) 1.06
Transmissible spongiform encephalopathies in humans. Annu Rev Microbiol (1999) 1.04
Transfusion transmission of human prion diseases. Transfus Med Rev (2008) 0.95
Creutzfeldt-Jakob disease surveillance and diagnosis. Clin Infect Dis (2005) 0.94
Mechanism of intestinal entry of infectious prion protein in the pathogenesis of variant Creutzfeldt-Jakob disease. Adv Drug Deliv Rev (2004) 0.89
Variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Clin Lab Med (2002) 0.86
Death certificates: an efficient source for ascertainment of Creutzfeldt-Jakob disease cases. Neuroepidemiology (1995) 0.86
Descriptive epidemiology of Creutzfeldt-Jakob disease in Finland. Acta Neurol Scand (1988) 0.85
Creutzfeldt-Jakob disease in the elderly. Postgrad Med J (1997) 0.81
Variant Creutzfeldt-Jakob disease death, United States. Emerg Infect Dis (2005) 0.79
Creutzfeldt-Jakob disease: Australian surveillance update to December 2005. Commun Dis Intell Q Rep (2006) 0.78
Epidemiological study of Creutzfeldt-Jakob disease death certificates in Canada, 1979-2001. Neuroepidemiology (2004) 0.78
Creutzfeldt-Jakob disease in the last 5 years in Hungary. Eur J Epidemiol (1991) 0.77
Deaths: final data for 2006. Natl Vital Stat Rep (2009) 6.89
Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med (2005) 6.83
Deaths: final data for 2010. Natl Vital Stat Rep (2013) 5.95
Deaths: final data for 2008. Natl Vital Stat Rep (2011) 5.31
The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2008) 3.79
Deaths: final data for 2004. Natl Vital Stat Rep (2007) 3.73
Deaths: preliminary data for 2009. Natl Vital Stat Rep (2011) 3.53
Deaths: final data for 2007. Natl Vital Stat Rep (2010) 3.45
Deaths: final data for 2009. Natl Vital Stat Rep (2011) 3.18
Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis (2005) 3.15
Deaths: preliminary data for 2008. Natl Vital Stat Rep (2010) 3.12
PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology (2013) 3.02
Rapidly progressive dementia. Ann Neurol (2008) 3.00
A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol (2008) 2.95
Annual summary of vital statistics: 2005. Pediatrics (2007) 2.92
Deaths: final data for 2000. Natl Vital Stat Rep (2002) 2.65
Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J Neurosci (2005) 2.46
Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics (2003) 2.36
West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clin Infect Dis (2006) 2.30
Deaths: final data for 2001. Natl Vital Stat Rep (2003) 2.26
Evaluation and validation of a real-time polymerase chain reaction assay for rapid identification of Bacillus anthracis. Emerg Infect Dis (2002) 2.23
Kawasaki syndrome and factors associated with coronary artery abnormalities in California. Pediatr Infect Dis J (2012) 2.03
Management of neurosurgical instruments and patients exposed to Creutzfeldt-Jakob disease. Infect Control Hosp Epidemiol (2013) 2.02
Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis (2012) 2.01
Necrotising enterocolitis hospitalisations among neonates in the United States. Paediatr Perinat Epidemiol (2006) 1.97
Annual summary of vital statistics--2003. Pediatrics (2005) 1.95
Infectious disease hospitalizations among infants in the United States. Pediatrics (2008) 1.90
West nile virus RNA not detected in urine of 40 people tested 6 years after acute West Nile virus disease. J Infect Dis (2010) 1.88
Chronic wasting disease and potential transmission to humans. Emerg Infect Dis (2004) 1.87
Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. J Pediatr (2004) 1.84
Deaths: Final Data for 2013. Natl Vital Stat Rep (2016) 1.83
Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J (2010) 1.78
Persistent neuroinvasive West Nile virus infection in an immunocompromised patient. Clin Infect Dis (2006) 1.76
Mortality in the United States, 2013. NCHS Data Brief (2014) 1.75
An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study. Lancet Neurol (2009) 1.73
Annual summary of vital statistics--2001. Pediatrics (2002) 1.73
Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol (2012) 1.70
Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol (2010) 1.66
Kawasaki syndrome hospitalizations among children in the United States, 1988-1997. Pediatrics (2003) 1.62
Distribution of eosinophilic meningitis cases attributable to Angiostrongylus cantonensis, Hawaii. Emerg Infect Dis (2007) 1.54
Leptospirosis, water sports, and chemoprophylaxis. Clin Infect Dis (2002) 1.54
Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. Pediatr Infect Dis J (2006) 1.46
Nodding syndrome. Emerg Infect Dis (2013) 1.45
Infectious disease hospitalizations in the United States. Clin Infect Dis (2009) 1.43
Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol (2013) 1.42
Cause-specific mortality after first cerebral infarction: a population-based study. Stroke (2003) 1.39
Iatrogenic Creutzfeldt-Jakob disease in Australia: time to amend infection control measures for pituitary hormone recipients? Med J Aust (2010) 1.39
Trends in preterm-related infant mortality by race and ethnicity, United States, 1999-2004. Int J Health Serv (2007) 1.37
An Epidemiologic Investigation of Potential Risk Factors for Nodding Syndrome in Kitgum District, Uganda. PLoS One (2013) 1.36
First case of bioterrorism-related inhalational anthrax in the United States, Palm Beach County, Florida, 2001. Emerg Infect Dis (2002) 1.34
The public health impact of prion diseases. Annu Rev Public Health (2005) 1.33
Occupationally acquired human immunodeficiency virus (HIV) infection: national case surveillance data during 20 years of the HIV epidemic in the United States. Infect Control Hosp Epidemiol (2003) 1.29
Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans. Am J Epidemiol (2012) 1.27
Kawasaki syndrome in Denmark. Pediatr Infect Dis J (2007) 1.24
Kawasaki syndrome in Hawaii. Pediatr Infect Dis J (2005) 1.24
Host genetic risk factors for West Nile virus infection and disease progression. PLoS One (2011) 1.22
Monitoring the occurrence of emerging forms of Creutzfeldt-Jakob disease in the United States. Neurology (2003) 1.19
Eosinophilic meningitis attributable to Angiostrongylus cantonensis infection in Hawaii: clinical characteristics and potential exposures. Am J Trop Med Hyg (2011) 1.18
Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med J (2010) 1.17
Infectious disease hospitalizations among older adults in the United States from 1990 through 2002. Arch Intern Med (2005) 1.15
Delayed mortality in a cohort of persons hospitalized with West Nile virus disease in Colorado in 2003. Vector Borne Zoonotic Dis (2011) 1.13
Trends in lower respiratory tract infection hospitalizations among American Indian/Alaska Native children and the general US child population. J Pediatr (2012) 1.12
Disparities in infectious disease hospitalizations for American Indian/ Alaska Native people. Public Health Rep (2011) 1.10
Deaths: Final Data for 2014. Natl Vital Stat Rep (2016) 1.09
Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan. Pediatr Infect Dis J (2008) 1.09
Mortality in the United States, 2012. NCHS Data Brief (2014) 1.09
Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. Neuroepidemiology (2005) 1.08
Death in the United States, 2007. NCHS Data Brief (2009) 1.07
Methicillin-resistant Staphylococcus aureus-associated hospitalizations among the American Indian and Alaska native population. Clin Infect Dis (2009) 1.07
Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illness. J Infect Dis (2008) 1.07
Re: Examining the Association Between Kawasaki Disease and Pertussis. Epidemiology (2015) 1.07
Lower risk of Creutzfeldt-Jakob disease in pituitary growth hormone recipients initiating treatment after 1977. J Clin Endocrinol Metab (2011) 1.06